Clairvoyant Therapeutics

Vancouver, Canada

Clairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.

Jul 2022

Seed

Biotechnology Pharmaceutical Therapeutics

Top Investors

Negev Capital Origin Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Clairvoyant Therapeutics

Who are Clairvoyant Therapeutics's investors?

Clairvoyant Therapeutics's investors include Negev Capital, Origin Therapeutics.

Where is Clairvoyant Therapeutics headquartered?

Clairvoyant Therapeutics is headquartered in Vancouver, Canada.

What does Clairvoyant Therapeutics do?

Clairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.

What stage is Clairvoyant Therapeutics at?

Clairvoyant Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 7, 2022.

MLA

"Clairvoyant Therapeutics — Funding & Investors." VCBacked, July 7, 2022, https://www.vcbacked.co/company/clairvoyant-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2022). Clairvoyant Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/clairvoyant-therapeutics

Wikipedia (cite web)

{{cite web |title=Clairvoyant Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/clairvoyant-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 7, 2022.